Linkage to care of HbsAg-positive and anti-HCV-positive patients after a systematic screening approach in the German primary care setting

    loading  Checking for direct PDF access through Ovid



Identification of previously unknown cases is important to lower the burden of chronic hepatitis B and C infection. However, a screening program in the primary care setting has not yet been established. Therefore, a systematic screening project was conducted in 21 008 patients (Wolffram and colleagues). Here, we describe linkage to care of identified HbsAg-positive and anti-hepatitis C virus (HCV)-positive patients.


General practitioners characterized further medical care by a standardized questionnaire. Data of 48/110 HbsAg-positive and 114/199 anti-HCV-positive patients were available. An APRI index more than 2 or up to 0.5 indicated the presence of cirrhosis or the absence of fibrosis.


APRI was calculated in 32/48 hepatitis B virus (HBV) patients (>2: n=1; ≤0.5: n=29) and 34/114 HCV patients (>2: n=4; ≤0.5: n=23). The general practitioners were already aware of the positive HBsAg and anti-HCV-test in 13/48 and 59/114 patients, respectively.


For 29/35 newly diagnosed HBV patients and 26/55 HCV patients, further diagnostics were initiated: ultrasound 77 versus 38%, liver biopsy 20 versus 4%, and gastroscopy 20 versus 7%.


Antiviral treatment was initiated in 5/35 HBV cases and in 10/55 HCV patients.


A family screening was initiated in 22/35 HBV versus 13/55 HCV index patients and showed one additional HbsAg-positive and two anti-HCV-positive cases.


Diagnostic procedures differed significantly between anti-HCV-positive and HbsAg-positive patients (P<0.001 for APRI, ultrasound, and family screening; P=0.03 for liver biopsy).


Diagnostic procedures should be improved for hepatitis C-infected patients. The APRI index was only of limited value in the primary care setting.

Related Topics

    loading  Loading Related Articles